XML 21 R12.htm IDEA: XBRL DOCUMENT
v3.24.2.u1

Notes Receivable, Net | 6 Months Ended
--- | ---
Jun. 30, 2024
Receivables [Abstract] |
Notes Receivable, net | Note 4 – Notes Receivable, net The Company’s notes receivable, net consists of investments in loans to buyers of charged-off and nonperforming receivable portfolios through HGC and financing of laboratory equipment sales through ALT. As of June 30, 2024 and December 31, 2023, the Company’s outstanding notes receivables related to loans to buyers of charged-off and nonperforming receivable portfolios, net of unamortized deferred fees and costs on originated loans, and adjusted for the reserve for credit losses was $13.4 million and $17.5 million, respectively. The activity during the six months ended June 30, 2024 includes the additional investment in notes receivable of approximately $4.3 million, which was offset by principal payments made by borrowers of approximately $6.1 million and noncash transfer of notes receivable to equity method investments of approximately $2.5 million. As of June 30, 2024, the Company’s outstanding notes receivables related to financing of laboratory equipment sales, net of unamortized deferred fees and costs on originated loans and adjusted for the reserve for credit losses was $0.2 million. There was no notes receivable balance related to financing of laboratory equipment sales as of December 31, 2023. The activity during the six months ended June 30, 2024 includes the investment in notes receivable of approximately $0.2 million, which was offset by immaterial principal payments made by purchasers, deferred financing fees, and allowance for credit losses. The table below shows the Company’s lending activity as of June 30, 2024 (in thousands):
|  | June 30, 2024 |
Notes receivable as of December 31, 2023 |  | $ | 18,262 |
Investment in notes receivable |  |  | 4,516 |
Noncash transfer of notes receivable to equity method investments |  |  | (2,487 | )
Principal repayments |  |  | (6,132 | )
Notes receivable, as of June 30, 2024 |  |  | 14,159 |
Deferred financing fees and costs, net |  |  | (95 | )
Allowance for credit loss |  |  | (466 | )
Notes receivable, net, June 30, 2024 |  | $ | 13,598 |
In accordance with ASC 326, the Company performs a review of notes receivable on a quarterly basis. During the six months ended June 30, 2024, the Company recorded a credit of $0.2 million to the provision for credit losses in selling, general and administrative expense on the consolidated statement of income, due to the decrease in balance of notes receivables. As of June 30, 2024 and December 31, 2023, the allowance for credit losses was approximately $0.5 million and $0.7 million, respectively. As of June 30, 2024, the amortized cost basis of notes receivable in nonaccrual status was $5.7 million.

X
- Definition The entire disclosure for financing receivable. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 310 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 42 -Subparagraph (a)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481962/310-10-50-42 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 310 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 12A -Publisher FASB -URI https://asc.fasb.org//1943274/2147481933/310-10-55-12A Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 310 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 44 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481962/310-10-50-44 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 310 -SubTopic 10 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//310-10/tableOfContent Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 310 -SubTopic 20 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//310-20/tableOfContent + Details
Name: | us-gaap_FinancingReceivablesTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_ReceivablesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration